PROCEPT BioRobotics (PRCT) Total Current Liabilities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Total Current Liabilities data on file, last reported at $63.6 million in Q1 2026.

• Quarterly Total Current Liabilities rose 22.23% year-over-year to $63.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.6 million (up 22.23% YoY) and the FY2025 annual result came in at $65.8 million, up 23.83% from the prior year.
• Total Current Liabilities declined to $63.6 million in Q1 2026 per PRCT's latest filing, from $65.8 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $65.8 million in Q4 2025 and bottomed at $14.8 million in Q1 2022.
• The 5-year median for Total Current Liabilities is $42.8 million (2024), against an average of $42.7 million.
• The widest annual swing landed in 2023, when Total Current Liabilities surged 120.26%; it then rose 0.47% in 2025.
• Tracing PRCT's Total Current Liabilities over 5 years: stood at $35.3 million in 2022, then surged by 30.14% to $45.9 million in 2023, then rose by 15.69% to $53.1 million in 2024, then climbed by 23.83% to $65.8 million in 2025, then dropped by 3.28% to $63.6 million in 2026.
• Per Business Quant, the three latest PRCT Total Current Liabilities figures stand at $63.6 million (Q1 2026), $65.8 million (Q4 2025), and $53.9 million (Q3 2025).

Peer Comparison